- Condition: Cardiovascular Disease
Interventions: Drug: N(t)RTI) + boosted protease inhibitors (PI/r); Drug: maraviroc + boosted protease inhibitors (PI/r); Drug: maraviroc + N(t)RTI)
Sponsors: Kirby Institute; Kirby Institute
Not yet recruiting - verified April 2012 - Condition: Osteoarthritis
Interventions: Other: Hospital Inpatient Rehabilitation; Other: Hybrid Home Programme (HO)
Sponsors: South West Sydney Local Health District; Mark Buhagiar; HammondCare
Not yet recruiting - verified April 2012 - Conditions: Unipolar Depression; Bipolar Depression
Interventions: Device: Sham tDCS device; Device: Soterix tDCS device
Sponsors: The University of New South Wales; The University of New South Wales; Duke University; Emory University; Sheppard Pratt Health System; University of Medicine and Dentistry New Jersey; University of Texas
Not yet recruiting - verified March 2012 - Condition: Duodenal Diseases
Intervention: Other: Tissue Sampling
Sponsors: South West Sydney Local Health District; South West Sydney Local Health District
Recruiting - verified March 2012 - Condition: Constriction, Pathological
Intervention: Device: Fully coated, removable , self-expanding oesophageal stent
Sponsors: South West Sydney Local Health District; South West Sydney Local Health District
Recruiting - verified March 2012 - Condition: Metastatic Melanoma
Intervention: Radiation: Whole Brain Radiotherapy
Sponsors: Australia and New Zealand Melanoma Trials Group; Australia and New Zealand Melanoma Trials Group; Trans-Tasman Radiation Oncology Group (TROG); Sydney Neuro-Oncology Group
Recruiting - verified January 2012 - Condition: Depression
Interventions: Other: OxIGen + iCBT; Other: Waitlist Control
Sponsors: St Vincent's Hospital, Sydney; Alishia Williams; The University of New South Wales
Recruiting - verified March 2012 - Conditions: Vertebral Compression Fractures; Osteoporotic Vertebral Compression Fractures; Acute Vertebral Fractures
Intervention: Procedure: Vertebroplasty
Sponsors: Optimus Clinical Research; Optimus Clinical Research; Care Fusion
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Optimus Clinical Research; Optimus Clinical Research; Arthritis Australia, Abbott Australia
Recruiting - verified November 2011 - Conditions: Diabetes Mellitus, Type 2; Insulin Resistance
Interventions: Dietary Supplement: Zinc supplements; Dietary Supplement: Omega 3 supplements; Dietary Supplement: Placebo supplements
Sponsors: University of Sydney; University of Sydney
Completed - verified January 2012 - Condition: Septic Shock
Interventions: Drug: Hydrocortisone; Drug: Water for injection
Sponsors: The George Institute; The George Institute; National Health and Medical Research Council, Australia; Australian and New Zealand Intensive Care Society Clinical Trials Group
Not yet recruiting - verified February 2012 - Condition: Peripheral Arterial Disease
Intervention: Device: stent
Sponsors: Flanders Medical Research Program; Flanders Medical Research Program
Recruiting - verified September 2011 - Condition: Major Depressive Episode
Interventions: Drug: Ketamine; Drug: Saline (placebo)
Sponsors: The University of New South Wales; The University of New South Wales; Wesley Hospital, Kogarah
Recruiting - verified November 2011 - Conditions: HIV-1 Infection; Cardiovascular Disease
Interventions: Other: Control; Other: Intervention Group
Sponsors: Holdsworth House Medical Practice; Holdsworth House Medical Practice
Recruiting - verified November 2011 - Condition: HIV-1-Associated Cognitive Motor Complex
Intervention:
Sponsors: Holdsworth House Medical Practice; Holdsworth House Medical Practice
Recruiting - verified November 2011 - Conditions: Ischemic Stroke; High Blood Pressure
Interventions: Drug: Low-dose rtPA; Drug: Standard-dose rtPA; Other: BP management policies; Other: BP management policies
Sponsors: The George Institute; The George Institute; National Health and Medical Research Council, Australia
Recruiting - verified March 2012 - Condition: Ulcerative Colitis
Interventions: Drug: Rectal tactolimus; Drug: Placebo
Sponsors: The University of Western Australia; The University of Western Australia; Mater Health Services' Adult Hospital, Brisbane, Qld; Concord Hospital; The Canberra Hospital; Royal Prince Alfred Hospital, Sydney, Australia
Not yet recruiting - verified August 2011 - Condition: Urinary Retention
Intervention: Device: clean intermittent self catheterisation single use vs re use
Sponsors: St George Hospital, Australia; St George Hospital, Australia
Recruiting - verified March 2010 - Conditions: Colonic Polyp; Colon Cancer
Intervention: Other: Sample of polyp
Sponsors: South West Sydney Local Health District; South West Sydney Local Health District
Recruiting - verified March 2012 - Conditions: Prostate Cancer (Post Prostatectomy); Anal Cancer; Nasopharyngeal Cancer; Intermediate Risk Prostate Cancer
Intervention: Other: Non-Interventional Study
Sponsors: Trans-Tasman Radiation Oncology Group (TROG); Trans-Tasman Radiation Oncology Group (TROG)
Recruiting - verified June 2011 - Condition: Colonic Polyps
Interventions: Procedure: Circumferential Submucosal Incision Resection; Procedure: Endoscopic Muscosal Resection
Sponsors: South West Sydney Local Health District; South West Sydney Local Health District
Recruiting - verified March 2012 - Condition: Colonic Polyps
Intervention: Procedure: Endoscopic Mucosal Resection
Sponsors: South West Sydney Local Health District; South West Sydney Local Health District
Recruiting - verified March 2012 - Condition: Adenomatous Polyp of Large Intestine
Intervention: Procedure: Prophylactic use of coagulation therapy
Sponsors: South West Sydney Local Health District; South West Sydney Local Health District
Recruiting - verified March 2012 - Condition: Acute Hepatitis C
Interventions: Drug: Peginterferon alfa-2a; Drug: Ribavirin
Sponsors: Kirby Institute; Kirby Institute
Not yet recruiting - verified April 2011 - Condition: Major Depression
Interventions: Device: Eldith Company - direct current stimulator; Device: Eldith Company - direct current stimulator; Device: Eldith Company - direct current stimulator
Sponsors: The University of New South Wales; The University of New South Wales
Recruiting - verified March 2012 - Condition: Cognition
Intervention: Procedure: Transcranial direct current stimulation (tDCS)
Sponsors: The University of New South Wales; The University of New South Wales
Recruiting - verified September 2010 - Condition: Bipolar Disorder
Intervention: Device: Transcranial direct current stimulation (Eldith DC Stimulator)
Sponsors: The University of New South Wales; The University of New South Wales
Recruiting - verified April 2011 - Condition: Effects on Learning
Intervention: Device: Transcranial direct current stimulation (tDCS)
Sponsors: The University of New South Wales; The University of New South Wales
Recruiting - verified March 2011 - Conditions: Cystic Fibrosis; Bronchiectasis
Interventions: Drug: Azithromycin; Drug: Placebo control
Sponsors: Queensland Children's Medical Research Institute; Queensland Children's Medical Research Institute; Telethon Institute for Child Heath Research
Enrolling by invitation - verified May 2012 - Condition: Major Depression
Intervention: Device: tDCS (Eldith DC-Stimulator (CE certified))
Sponsors: The University of New South Wales; The University of New South Wales
Recruiting - verified March 2012 - Condition: Spinal Cord Injury
Interventions: Device: Therastride Treadmill System; Device: FES-assisted cycling; Other: Trunk and upper and lower limb exercises; Other: Upper body strength and fitness program
Sponsors: University of Melbourne; University of Melbourne; Victorian Neurotrauma Initiative; Life Time Care and Support Authority (NSW); The University of Western Australia
Recruiting - verified August 2010 - Condition: Traumatic Brain Injury
Interventions: Drug: Paracetamol; Drug: 0.9% Sodium Chloride Schedule:
Sponsors: South East Sydney and Illawarra Area Health Service; South East Sydney and Illawarra Area Health Service; The George Institute; The University of New South Wales; Royal Brisbane and Women's Hospital
Recruiting - verified May 2010 - Condition: Major Depression
Intervention: Device: tDCS (Eldith DC-Stimulator (CE certified))
Sponsors: The University of New South Wales; The University of New South Wales
Recruiting - verified March 2012 - Conditions: Diabetic Retinopathy; Macular Edema
Interventions: Drug: bevacizumab; Drug: dexamethasone
Sponsors: University of Sydney; University of Sydney; National Health and Medical Research Council, Australia
Recruiting - verified February 2012 - Condition: Gestational Hypertension
Interventions: Procedure: Intervention is blood pressure management approach; Procedure: Intervention is blood pressure management approach.
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR); Sunnybrook Research Institute
Recruiting - verified December 2011 - Condition: Delirium
Interventions: Drug: Dexmedetomidine; Drug: Saline placebo
Sponsors: Austin Health; Austin Health; Hospira Pty Ltd
Recruiting - verified May 2010 - Condition: Ankle Fractures
Interventions: Procedure: Open reduction internal fixation of the ankle; Procedure: Non Operative
Sponsors: The University of New South Wales; The University of New South Wales; Whitlam Orthopaedic Research Centre; CROSSBAT Investigators
Recruiting - verified January 2012 - Conditions: Infant, Premature, Diseases; Bronchopulmonary Dysplasia; Retinopathy of Prematurity; Infant, Newborn, Diseases; Infant, Very Low Birth Weight
Interventions: Procedure: Higher oxygen saturation target range (91%-95%); Procedure: Lower oxygen saturation (85%-89%)
Sponsors: University of Sydney; University of Sydney; University of Otago; University of Oxford; University of Pennsylvania; University of California, San Diego
Recruiting - verified August 2011 - Conditions: Cystic Fibrosis; Diabetes
Intervention: Drug: Once-daily insulin detemir
Sponsors: Sydney Children's Hospital; Sydney Children's Hospital; The Children's Hospital at Westmead; John Hunter Children's Hospital
Recruiting - verified July 2011 - Condition: Spinal Cord Injury
Interventions: Device: ReJoyce Workstation; Other: Standard Care
Sponsors: University of Melbourne; University of Melbourne; Victorian Neurotrauma Initiative; Lifetime Care and Support Authority (NSW); The University of Western Australia
Recruiting - verified March 2010 - Conditions: Chronic Medical Conditions; Personal Health Records; Electronic Medical Record
Interventions: Device: Electronic (USB) Portable Health File; Device: Paper Portable Health File
Sponsors: St George Hospital, Australia; St George Hospital, Australia; South Eastern Area Health Service; The University of New South Wales; National Health and Medical Research Council, Australia
Recruiting - verified December 2011 - Condition: Major Depression
Intervention: Device: tDCS (Eldith DC-Stimulator (CE certified))
Sponsors: The University of New South Wales; The University of New South Wales
Recruiting - verified March 2012 - Condition: HIV Infections
Interventions: Drug: Efavirenz; Drug: Efavirenz
Sponsors: Kirby Institute; Kirby Institute
Recruiting - verified November 2011 - Condition: Traumatic Brain Injury
Interventions: Drug: Epoetin Alfa; Drug: Placebo, Sodium Chloride
Sponsors: Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Research Centre; National Health and Medical Research Council, Australia; Victorian Neurotrauma Initiative; Australian and New Zealand Intensive Care Society Clinical Trials Group; Monash University
Recruiting - verified April 2012 - Condition: Severe Sepsis
Interventions: Other: Standard Care; Other: Early Goal Directed Therapy (EGDT)
Sponsors: Monash University; Belinda Howe; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australasian College for Emergency Medicine
Recruiting - verified April 2012 - Condition: Latent Tuberculosis Infection
Interventions: Drug: Isoniazid; Drug: Rifampin
Sponsors: McGill University; McGill University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified June 2011 - Condition: Depression
Interventions: Device: rTMS 5 x weekly; Device: rTMS 3 times weekly
Sponsors: Northside Clinic, Australia; Northside Clinic, Australia
Terminated - verified July 2011 - Condition: Stroke
Interventions: Drug: Tissue Plasminogen Activator (Alteplase); Drug: Placebo
Sponsors: National Stroke Research Institute, Australia; National Stroke Research Institute, Australia; Commonwealth Scientific & Industry Research Organisation; Brain Research Institute; University of Melbourne; Melbourne Health
Recruiting - verified May 2012 - Condition: HIV Infection
Interventions: Drug: atazanavir plus raltegravir; Drug: atazanavir plus raltegravir
Sponsors: Kirby Institute; Kirby Institute
Completed - verified April 2010 - Condition: Major Depressive Disorder
Interventions: Procedure: bilateral ultrabrief ECT; Procedure: bilateral standard ECT; Procedure: right-unilateral ultrabrief ECT; Procedure: right-unilateral standard ECT
Sponsors: The University of New South Wales; The University of New South Wales; Northside Clinic, Australia; The Melbourne Clinic, Australia; St George Hospital, Australia; Wandene Private Hospital, Australia
Recruiting - verified September 2011 - Conditions: Breast Neoplasms; Heart Failure
Intervention:
Sponsors: Royal Prince Alfred Hospital, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia
Recruiting - verified July 2011 - Condition: Hepatitis B
Intervention: Other: Incentive condition
Sponsors: Kirby Institute; Kirby Institute
Completed - verified June 2011 - Conditions: Intracerebral Hemorrhage; Stroke; Hypertension
Intervention: Other: Blood pressure management policies
Sponsors: The George Institute; The George Institute; National Health and Medical Research Council, Australia
Recruiting - verified February 2012 - Condition: Major Depressive Episode
Interventions: Drug: Ketamine; Drug: Saline
Sponsors: Northside Clinic, Australia; Northside Clinic, Australia; Wesley Hospitals
Recruiting - verified September 2011 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Conditions: Female Genital Diseases; Ovarian Cancer; Cervical Cancer; Endometrial Cancer; Vulval Cancer
Intervention:
Sponsors: Queensland Centre for Gynaecological Cancer; Queensland Centre for Gynaecological Cancer; The University of Queensland; Royal Brisbane and Women's Hospital; Mater Health Services, Brisbane; Mater Private Hospital; Queensland Institute of Medical Research; Queensland University of Technology; Australia New Zealand Gynaecological Oncology Group; Cancer Australia
Active, not recruiting - verified June 2011 - Condition: Breast Cancer
Interventions: Drug: Letrozole; Drug: Letrozole
Sponsors: International Breast Cancer Study Group; International Breast Cancer Study Group
Recruiting - verified March 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Biological: bevacizumab; Drug: carboplatin; Drug: paclitaxel; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Medical Research Council
Recruiting - verified April 2012 - Condition: Prostate Cancer
Interventions: Procedure: 7800 cGy/39 fractions in 8 weeks; Procedure: 6000 cGy/20 fractions in 4 weeks
Sponsors: Ontario Clinical Oncology Group (OCOG); Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified October 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Radiation: radiation therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group; British Medical Research Council; Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified February 2012 - Condition: Latent Tuberculosis Infection
Intervention: Drug: Isoniazide (drug), Rifampin (drug)
Sponsors: McGill University; McGill University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified June 2011 - Condition: HIV Infections
Interventions: Drug: ondansetron, ibuprofen, paracetamol; Drug: Ondansetron, ibuprofen, paracetamol; Drug: metoclopramide, ibuprofen, paracetamol; Drug: Metoclopramide, codeine phosphate, ibuprofen, paracetamol
Sponsors: Kirby Institute; Kirby Institute; The University of New South Wales
Terminated - verified April 2012 - Condition: Brain and Central Nervous System Tumors
Interventions: Biological: filgrastim; Drug: cisplatin; Drug: cyclophosphamide; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Radiation: radiation therapy
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital
Recruiting - verified January 2012 - Condition: Breast Cancer
Intervention: Drug: anastrozole
Sponsors: Queen Mary University of London; Jill Knox
Active, not recruiting - verified April 2012 - Condition: Breast Cancer
Interventions: Procedure: axillary lymph node dissection; Procedure: No axillary lymph node dissection
Sponsors: International Breast Cancer Study Group; International Breast Cancer Study Group
Active, not recruiting - verified February 2012 - Condition: Pancreatic Cancer
Interventions: Drug: erlotinib hydrochloride; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Breast Cancer
Interventions: Drug: CAF regimen; Drug: CMF regimen; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: epirubicin hydrochloride; Drug: fluorouracil; Drug: methotrexate; Procedure: adjuvant therapy
Sponsors: National Cancer Institute (NCI); International Breast Cancer Study Group
Recruiting - verified September 2008 - Condition: Head and Neck Cancer
Interventions: Biological: epoetin alfa; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); European Organization for Research and Treatment of Cancer - EORTC; Trans-Tasman Radiation Oncology Group (TROG); Charite University, Berlin, Germany; Groupe Oncologie Radiotherapie Tete et Cou; Radius Hungaricus Oncology Group; Grup per l'Estudi dels Limfomes de Catalunya i Balears
Active, not recruiting - verified June 2006 - Condition: Lung Cancer
Interventions: Biological: BCG vaccine; Biological: monoclonal antibody BEC2
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC
Completed - verified March 2012
 |
Join Clinical Trials by University in New South Wales, Australia |
